Treasury Rejects Proposal to Cut VAT on Public EV Charging to 5 Wall Street Sentiment Shifts Positive for CoreWeave on AI Demand Outlook Judge Dismisses Criminal Case Against Wrongfully Deported Individual Legal and Market Implications SpaceX OpenAI Anthropic Could Surpass Berkshire Hathaway in FirstDay Trading Value Polymarket Myanmars Political Transition CPJ Urges Press Freedom Benchmarks UK Chancellor Rachel Reeves Unveils VAT Cut on Summer Activities to Ease Cost of Living Pressures STKS Q1 2026 Earnings WiderthanExpected Loss as EPS Misses Estimates Significantly Southwest Gas Holdings SWX Q1 2026 Earnings Mixed Start as EPS Falls Short of Estimates IN8bio Inc INAB Q1 2026 Earnings Narrowed Loss Beats Expectations Stock Rises BDCI Q1 2026 Earnings Positive EPS of 005 Reported Despite Absence of Revenue Details EH Q4 2025 Earnings Massive EPS Beat Drives Positive Surprise Despite Revenue Absence Teladoc Health Q1 2026 Earnings EPS Misses Expectations as Cost Pressures Persist Applovin APP Edges Lower Holds Within Recent Trading Range Palmer Square Capital BDC PSBD Edges Higher as Price Nears Resistance Level zSpace Inc ZSPC Declines 774 as Shares Challenge Critical 013 Support Zone TMobile US Inc 5500 Senior Notes TMUSZ Inch Higher as Investors Seek FixedIncome Stability Odyssey Marine Exploration OMEX Edges Higher as It Tests Key Resistance Zone Amazon Reports RecordBreaking Thanksgiving Holiday Week Sales Greenlight Capital Re Ltd Q1 2026 Earnings Strong EPS Performance Amid Market Headwinds California BanCorp BCAL Holds Steady with Modest Gain as Stock Nears Resistance TSUI Slides 73 as Sui Ecosystem Faces Renewed Selling Pressure Astrana Health Inc ASTH Edges Higher Testing Key Resistance Zone Better Home Finance Holding BETR Surges 232 as Buyers Defend Key Support Assured Guaranty AGO Slightly Lower as Stock Holds Near Key Technical Levels Bold Eagle Acquisition Corp BEAG Holds Steady at 1058 as SPAC Market Awaits Catalyst Aclaris Therapeutics Holds Steady Near MidRange as Traders Eye Key Support and Resistance Gyre Therapeutics GYRE Falters Testing Key Support After 194 Decline